Coverage Universe
Companies work with LifeSci Capital because of our distinct influence over investor engagement and behavior
Sort by Sector
Abivax
(ABVX.PA)
Analyst: Adam Evertts
Immunology and inflammation
Aeglea
(AGLE)
Analyst: Sam Slutsky
Rare disease
Akili Interactive
(AKLI)
Analyst: Rahul Rakhit
Digital Health
Allakos
(ALLK)
Analyst: Sam Slutsky
Immunology and inflammation
ALX Oncology
(ALXO)
Analyst: Adam Evertts
Oncology
Astria Therapeutics
(ATXS)
Analyst: Sam Slutsky
Rare disease
Avadel
(AVDL)
Analyst: Adam Evertts
CNS
Bellus
(BLU)
Analyst: Sam Slutsky
Respiratory
BetaBionics
(Private)
Analyst: Rahul Rakhit
Medical technology
Better Therapeutics
(BTTX)
Analyst: Rahul Rakhit
Digital Health
Calliditas
(CALT)
Analyst: Rami Katkhuda
Nephrology
Catalyst Biosciences
(CBIO)
Analyst: Sam Slutsky
Immunology and inflammation
Celldex
(CLDX)
Analyst: Sam Slutsky
Immunology and inflammation
CinCor Pharma
(CINC)
Analyst: Rami Kathkhuda
Cardiovascular
Cogent
(COGT)
Analyst: Sam Slutsky
Oncology
CymaBay
(CBAY)
Analyst: Patrick Dolezal
Rare disease
DarioHealth
(DRIO)
Analyst: Rahul Rakhit
Digital Health
Eledon
(ELDN)
Analyst: Rami Katkhuda
Immunology and inflammation
Enliven Therapeutics
(ELVN)
Analyst: Sam Slutsky
Oncology
Immunovant
(IMVT)
Analyst: Sam Slutsky
Immunology and inflammation
InflaRx
(IFRX)
Analyst: Sam Slutsky
Immunology and inflammation
Inhibrx
(INBX)
Analyst: Adam Evertts
Rare disease
Larimar
(LRMR)
Analyst: Patrick Dolezal
Rare disease
Lucira Health
(LHDX)
Analyst: Rahul Rakhit
Diagnostics
MEI Pharma
(MEIP)
Analyst: Adam Evertts
Oncology
Moonlake Immunotherapeutics
(MLTX)
Analyst: Rami Kathkhuda
Immunology and inflammation
Nano-X Imaging
(NNOX)
Analyst: Rahul Rakhit
Medical technology
Olema
(OLMA)
Analyst: Adam Evertts
Oncology
Orchestra Biomed
(OBIO)
Analyst: Rahul Rakhit
Medical technology
Pear Therapeutics
(PEAR)
Analyst: Rahul Rakhit
Digital Health
Pyxis Oncology
(PYXS)
Analyst: Adam Evertts
Oncology
Rain Oncology
(RAIN)
Analyst: Sam Slutsky
Oncology
Rocket Pharmaceuticals
(RCKT)
Analyst: Patrick Dolezal
Genetic medicines
Tarsus
(TARS)
Analyst: Patrick Dolezal
Opthalmology
Tenaya Therapeutics
(TNYA)
Analyst: Patrick Dolezal
Genetic medicines
Third Harmonic Bio
(THRD)
Analyst: Sam Slutsky
Immunology and inflammation
VectivBio
(VECT)
Analyst: Patrick Dolezal
Rare disease
Ventyx
(VTYX)
Analyst: Sam Slutsky
Immunology and inflammation
Vera Therapeutics
(VERA)
Analyst: Rami Katkhuda
Nephrology
Verve
(VERV)
Analyst: Patrick Dolezal
Genetic medicines
Vincerx
(VINC)
Analyst: Adam Evertts
Oncology
Viridian Therapeutics
(VRDN)
Analyst: Rami Katkhuda
Immunology and inflammation
VYNE Therapeutics
(VYNE)
Analyst: Patrick Dolezal